Paragraph 10 Decentralised immunological application where the United Kingdom is the reference member State
(1)
The fee for a decentralised application for a marketing authorisation for an immunological product where the United Kingdom is the reference member State is the same as for a national application, with the additions of £3,420 for the first member State involved in the application and £520 for each additional member State.
(2)
In the case of a simultaneous application the fee for each additional product in the application is £6,570 for one member State and £120 for each additional member State.